Table 1.
Effect size |
Heterogeneity |
||||||
---|---|---|---|---|---|---|---|
Outcome | Studies (n) | Patients (n) | OR | 95% CI | P-value | I2 (%) | P-value |
30-day outcomes (cumulative events at within 30 days after the procedure) | |||||||
Mortality | 5 | 872 | 0.81 | 0.18–3.63 | 0.780 | 0 | 0.466 |
MI | 5 | 872 | 1.02 | 0.33–3.21 | 0.967 | 0 | 0.814 |
TVR | 3 | 497 | 2.28 | 0.37–14.16 | 0.375 | 0 | 0.820 |
Stroke | 5 | 872 | 1.30 | 0.17–9.87 | 0.802 | 0 | 0.446 |
MACCE | 3 | 497 | 1.22 | 0.41–3.63 | 0.721 | 0 | 0.681 |
Outcomes at latest follow-up (cumulative events at > 1 year follow-up after the procedure) | |||||||
Mortality | 7 | 27,041 | 0.84 | 0.64–1.10 | 0.203 | 0 | 0.669 |
MI | 7 | 1,149 | 0.40 | 0.20–0.80 | 0.010 | 0 | 0.519 |
TVR | 6 | 27,041 | 0.49 | 0.37–0.64 | <0.001 | 26 | 0.228 |
Stroke | 5 | 949 | 1.20 | 0.49–2.93 | 0.694 | 0 | 0.476 |
MACCE | 6 | 1,149 | 0.46 | 0.20–1.05 | 0.061 | 67 | 0.010 |
CI, confidence interval; MACCE, major adverse cardiac and cerebrovascular accidents; MI, myocardial infarction; OR, odds ratio; TVR, target vessel revascularization.